• Explore /
  • Poster
  • / The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer.

The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer.

Abstract Poster

Authors

null

Nancy Y. Lee

Memorial Sloan Kettering Cancer Center, New York, NY

Nancy Y. Lee , Eric Jeffrey Sherman , Heiko Schöder , Sean Matthew McBride , Yao Yu , Jung Kang , C. Jillian Tsai , Daphna Y. Gelblum , Jay Boyle , Bhuvanesh Singh , Marc Cohen , Jennifer R. Cracchiolo , Ian Ganly , Lara Dunn , Anuja Kriplani , James Vincent Fetten , Loren S. Michel , Richard J. Wong , David G. Pfister , Nadeem Riaz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT03323463

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 6019)

DOI

10.1200/JCO.2021.39.15_suppl.6019

Abstract #

6019

Abstract Disclosures

Similar Posters

First Author: Nadeem Riaz

First Author: Marshall R. Posner

Poster

2017 ASCO Annual Meeting

Optima: A phase II dose and volume de-escalation trial for high- and low-risk HPV+ oropharynx cancers.

Optima: A phase II dose and volume de-escalation trial for high- and low-risk HPV+ oropharynx cancers.

First Author: James Melotek

First Author: Ari Rosenberg